B044 clinical result search

{
  "limit": 10,
  "main_experimentation_drug": {
    "condition": "OR",
    "value": [
      "945fa31ebe9e41ae912e493aa3324576"
    ]
  },
  "overall_enrollment": {
    "from": 500,
    "to": 1000
  },
  "sort": [
    {
      "sort_field": "ANNOTATION_METHOD_RANK",
      "sort_order": "desc"
    }
  ],
  "disease": {
    "condition": "OR",
    "value": [
      "62eaee6d9ee44410b8aca59dfc7408e9"
    ]
  },
  "target": {
    "condition": "OR",
    "value": [
      "9786d32e3d244a688ec6a60d2fe1b10b"
    ]
  },
  "sponsor_collaborator_organization": {
    "condition": "OR",
    "value": [
      "6a8c172f1efc649035845f94c31a9c1e"
    ]
  },
  "study_code": [
    "KEYNOTE-045"
  ],
  "register_number": [
    "NCT02256436"
  ],
  "drug_type": {
    "condition": "OR",
    "value": [
      "c38eb408d6b842f487d6a27484156633"
    ]
  },
  "control_drug": {
    "condition": "OR",
    "value": [
      "095fdb04424f4214a7b26b7ff6877e67"
    ]
  },
  "therapeutic_area": [
    "62eaee6d9ee44410b8aca59dfc7408e9"
  ],
  "mechanism_action": {
    "condition": "OR",
    "value": [
      "4dd338b149b3ecd0ee860e1fb379b44f"
    ]
  },
  "ct_result_meeting": [
    "c47a5730bf5e40b3aa76c26820ec6d4e"
  ],
  "outcome": {
    "condition": "OR",
    "value": [
      "84a502e8ba664184bd01fbee1e8554c3"
    ]
  },
  "therapy_type": [
    "SECOND_LINE"
  ],
  "phase": [
    "Phase_3"
  ],
  "publish_time": {
    "from": 1483228800000,
    "to": 1514851199999
  },
  "general_evaluation": [
    "POSITIVE"
  ]
}

{
  "data": {
    "items": [
      {
        "title": "Matching-Adjusted Indirect Treatment Comparisons (MAIC) of Sotorasib 960mg (soto960) Plus Panitumumab (pani) Vs. Trifluridine/Tipiracil(T/T) Plus Bevacizumab (bev) in Chemorefractory Metastatic Colorectal Cancer (mCRC)",
        "ct_result_id": "2eadada4ed582332940e522e5258e52e"
      }
    ],
    "limit": 10,
    "total": 10
  },
  "error_msg": "The request parameter format is incorrect！"
}